Spinal Dopamine Mechanisms and Primary Sensory Symptoms in Parkinson's Disease

References

• Akil H., Liebeskind J. C. Monoaminergic mechanisms of stimulation‐produced analgesia. Brain Research 1975; 94: 278–296
   Web of Science ®Google Scholar
• Antonaccio M., Robson R. An analysis of the peripheral effects of L‐dopa on autonomic nerve function. British Journal of Pharmocology 1974; 52: 41–50
   PubMed Web of Science ®Google Scholar
• Barasi S., Pay S. Influence of striatal and limbic afferents on nociceptive nigral neurons. Advances in pain research und therapy, J. J. Bonica, U. Lindblom, A. Iggo. Raven Press, New York 1983; 169–177, (5)
   Google Scholar
• Barnes C. D., Fund S. J., Adams W. L. Inhibitory effects of substantia nigra on impulse transmission from nociceptors. Pain 1979; 6: 207–215
   PubMed Web of Science ®Google Scholar
• Battista A., Wolff B. Levodopa and induced‐pain response. Archives of Internal Medicine 1973; 132: 70–74
   PubMedGoogle Scholar
• Beckstead R. M., Domesick V. B., Nauta W. J. H. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Research 1978; 195: 191–217
   Google Scholar
• Bernthal P. J., Koss M. C. A spinal sympatho‐inhibitory action of chlorpromazine and haloperidol in the cat. Neuropharmacology 1979; 18: 697–700
   PubMed Web of Science ®Google Scholar
• Blessing W. W., Chalmers J. P. Direct projection of catecholamine (presumably dopamine)‐ containing neurons from hypothalamus to spinal cord. Neuroscience Letters 1979; 9: 35–40
   Google Scholar
• Cheng R. S. S., Pomeranz B. Monoaminergic mechanism of electro‐acupuncture analgesia. Brain Research 1981; 215: 77–92
   PubMed Web of Science ®Google Scholar
• Commissiong J. W., Gentelman S., Neff N. G. Spinal cord dopaminergic neurons: evidence for an uncrossed nigro‐spinal pathway. Neuropharmacology 1979; 18: 565–568
   PubMed Web of Science ®Google Scholar
• Coote J. H., MacLeod V. H., Fleetwood‐Walker S. The response of individual sympathetic preganglionic neurones to nicroelectrophoretically applied endogenous monamines. Brain Research 1981; 215: 135–145
   PubMed Web of Science ®Google Scholar
• Curzon G., Huston P. H., Tricklerbanik M. D. Involvement of dopamine in the analgesic response induced by foot‐shock. British Journal of Pharmacology 1981; 74: 761–765
   Web of Science ®Google Scholar
• Demenge P., Feuerstein B., Mouchet P., Guerin B. Stereospecific binding of 3H‐haloperidol in rat dorsal spinal cord. European Journal of pharmacology 1980; 66: 117–120
   PubMed Web of Science ®Google Scholar
• Demange P., Mouchet P., Guerin B., Feuerstein C. Identification and distribution of neuroleptic binding sites in the rat spinal cord. Journal of Neurochemistry 1981; 37: 53–59
   PubMed Web of Science ®Google Scholar
• Fields H. A. Brainstem mechanisms of pain modulation. Advances in pain research and therapy, L. Kruger, J. C. Liebeskind. Raven Press, New York 1984; 241–252, (6)
   Google Scholar
• Gentelman S., Parenti M., Commissiong J. W., Neff N. H. Dopamine activated adenylate cyclase of spinal cord: supersensitivy following transection of the cord. Brain Research 1981; 210: 271–275
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Sandyk R. Opioids, dopamine and restless legs syndrome. American Journal of Psychiatry 1985; 142: 662
   PubMed Web of Science ®Google Scholar
• Gonzales‐Vegas J. A. Nigro‐reticular pathway in the rat: an intracellular study. Brain Research 1981; 207: 170–173
   PubMed Web of Science ®Google Scholar
• Grossman W., Jurna I., Nell T., Theres C. The dependence of the anti‐nociceptive effect of morphine and other analgesic agents on spinal motor activity after central monoamine depletion. European Journal of Pharmacology 1973; 24: 66–77
   Web of Science ®Google Scholar
• Hokfelt T., Phillipson O., Goldstein H. Evidence for a dopaminergic pathway in the rat descending from A11 cell group to the spinal cord. Acta Physiology Scandinavia 1979; 107: 393–395
   PubMedGoogle Scholar
• Jensen T. S., Smith D. F. Dopaminergic effects on tail‐flick response in spinal rats. European Journal of Pharmacology 1982; 79: 129–133
   PubMed Web of Science ®Google Scholar
• Jurna I., Heinz G., Blinn G., Neil T. The effect of substantia nigra stimulation and morphine on alpha‐motorneurons and the tail‐flick response. European Journal of Pharmacology 1978; 51: 239–250
   PubMed Web of Science ®Google Scholar
• Kernbaum S., Hauchecorne J. Administration of levodopa for relief of herpes zoster pain. JAMA 1981; 246: 132–134
   PubMed Web of Science ®Google Scholar
• Koller W. C. The diagnosis of Parkinson's disease. Archives of Internal Medicine 1984; 144: 2146–2147
   PubMedGoogle Scholar
• Koller W. C. Sensory symptoms in Parkinson's disease. Neurology 1984; 34: 957–959
   PubMed Web of Science ®Google Scholar
• Langston J. W., Forno L. S. The hypothalamus in Parkinson disease. Annals of Neurology 1978; 3: 129–133
   PubMed Web of Science ®Google Scholar
• Lindvall O., Bjorklund A., Skagerberg G. Dopamine‐containing neurons in the spinal cord: anatomy and some functional aspects. Annals of Neurology 1983; 14: 255–260
   PubMed Web of Science ®Google Scholar
• Minton J. The response of breast cancer patients with bone pain to L‐dopa. Cancer 1974; 33: 358–362
   PubMed Web of Science ®Google Scholar
• Mouchet P., Guerin B., Feuerstein C. Dissociate destruction of noradrenaline and dopamine descending projections in the thoracic spinal cord of the rat. Life Sciences 1982; 30: 373–381
   PubMed Web of Science ®Google Scholar
• Price M. T. C., Fibiger H. C. Ascending catecholamine systems and morphine analgesia. Brain Research 1975; 99: 181–183
   Web of Science ®Google Scholar
• Rajput A. H., Rozdilsky B. Dysautonomia in Parkinsonism: a clincico‐pathological study. Journal of Neurology, Neurosurgery & Psychiatry 1976; 39: 1092–1100
   PubMed Web of Science ®Google Scholar
• Sandberg D. E., Segal M. Pharmacological analysis of analgesia and self‐stimulation elicited by electrical stimulation of catecholamine nuclei in the rat brain. Brain Research 1978; 152: 529–542
   PubMed Web of Science ®Google Scholar
• Sandyk R. Backache as an early symptom of Parkinson's disease. South African Medical Journal 1982a; 61: 3
   PubMed Web of Science ®Google Scholar
• Sandyk R. Sensory symptoms in Parkinson's disease. Pain. 1986; 25: 139–140
   PubMed Web of Science ®Google Scholar
• Sandyk R. Opiate responsive restless legs syndrome in Parkinson's disease. Journal of Clinical Psychiatry, (c)
   Google Scholar
• Shuster S., Burton J. L., Thody A. J. Melanocyte‐stimulating hormone and Parkinsonism. Lancet 1973; 1: 463–465
   PubMed Web of Science ®Google Scholar
• Sigwald J., Raymondeavo C. Les réactions déasagréable ou douloureuses de la méladie de Parkinson et de la théraputique neuroleptique (paresthesies. impatiences, cramps, akathisie). Leur amélioration par L'Alimenazine. Sem Hop Paris 1968; 44: 2897–2899
   PubMedGoogle Scholar
• Snider S. R., Fahn S., Isgreen W. P., Cote L. J. Primary sensory symptoms in Parkinsonism. Neurology 1976; 26: 423–429
   PubMed Web of Science ®Google Scholar
• Vanderwende C., Spoerlein M. T. Role of dopaminergic receptors in morphine analgesia and tolerance. Research Communications in Chemistry, Pathology, Pharmacology 1973; 5: 35–43
   PubMedGoogle Scholar
• Walker A., Nulsen F. Electrical stimulation of the upper thoracic portion of the sympathetic chain in man. Annals of Neurology 1948; 59: 559–560
   Google Scholar